US Stock Market Move | Moderna (MRNA.US) rises 5%, with its stock price approaching an all-time high.
On Monday, Moderna (MRNA.US) rose more than 8% in early trading, and as of press time, its gain narrowed to 5%, at $229.69.
On Monday, Moderna (MRNA.US) rose more than 8% in early trading, and as of press time, its gain narrowed to 5%, at $229.69, with the stock price approaching its all-time high. On the news front, on October 17, Moderna and Merck & Co., Inc. presented the Phase III melanoma study results for their personalized cancer therapy intismeran autogene in combination with Keytruda, and reports noted that the candidate therapy achieved positive progress.
Related Articles
A-share Evening Highlights | "One Central Bank and Two Commissions and One Regulatory Body" Make Major Statements on Capital Markets, Monetary Policy, and More
Haitian Water Group (603759.SH) Terminates Planning of Major Matters, Shares Resume Trading
Beihai Gofar Chuanshan Biological (600538.SH) plans a private placement to raise no more than 120 million yuan.
A-share Evening Highlights | "One Central Bank and Two Commissions and One Regulatory Body" Make Major Statements on Capital Markets, Monetary Policy, and More
Haitian Water Group (603759.SH) Terminates Planning of Major Matters, Shares Resume Trading
Beihai Gofar Chuanshan Biological (600538.SH) plans a private placement to raise no more than 120 million yuan.
